Historical Stock Price
AGE historical stock prices picture
AgeX Therapeutics (AGE) has the following price history information. Looking back at AGE historical stock prices for the last five trading days, on November 07, 2019, AGE opened at $1.47, traded as high as $1.56 and as low as $1.45, and closed at $1.46. Trading volume was a total of 35.50K shares. On November 08, 2019, AGE opened at $1.44, traded as high as $1.48 and as low as $1.44, and closed at $1.45. Trading volume was a total of 47.40K shares. On November 11, 2019, AGE opened at $1.45, traded as high as $1.49 and as low as $1.44, and closed at $1.46. Trading volume was a total of 18.50K shares. On November 12, 2019, AGE opened at $1.44, traded as high as $1.50 and as low as $1.44, and closed at $1.44. Trading volume was a total of 21.60K shares. On November 13, 2019, AGE opened at $1.44, traded as high as $1.48 and as low as $1.42, and closed at $1.43. Trading volume was a total of 47.10K shares.

AGE Historical Stock Prices By Date:

AGE historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into AgeX Therapeutics shares, starting with a $10,000 purchase of AGE, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 11/29/2018
End date: 11/13/2019
Start price/share: $2.71
End price/share: $1.43
Dividends collected/share: $0.00
Total return: -47.23%
Annualized Gain: -49.40%
Starting investment: $10,000.00
Ending investment: $5,277.00
Years: 0.96
Date Open High Low Close Volume
11/07/2019 $1.47 $1.56 $1.45 $1.46 35.50K
11/08/2019 $1.44 $1.48 $1.44 $1.45 47.40K
11/11/2019 $1.45 $1.49 $1.44 $1.46 18.50K
11/12/2019 $1.44 $1.50 $1.44 $1.44 21.60K
11/13/2019 $1.44 $1.48 $1.42 $1.43 47.10K
AgeX Therapeutics is a biotechnology company focused on the development and commercialization of therapeutics targeting human aging. Co.'s proprietary technology, based on telomerase-mediated cellular immortality and regenerative biology, allows Co. to utilize telomerase-expressing regenerative pluripotent stem cells (PSCs) for the manufacture of cell-based therapies to regenerate tissues afflicted with age-related chronic degenerative disease. Co.'s product candidates are in discovery stage: They include two cell-based therapies derived from telomerase-positive PSCs and one product candidate derived from its proprietary induced Tissue Regeneration technology.
Date Close
11/07/2019$1.46
11/08/2019$1.45
11/11/2019$1.46
11/12/2019$1.44
11/13/2019$1.43
AGE is categorized under the Materials sector; below are some other companies in the same sector:

AGFS Historical Stock Prices
AGH Historical Stock Prices
AGI Historical Stock Prices
AGL Historical Stock Prices
AGP Historical Stock Prices
AGQ Historical Stock Prices
AGU Historical Stock Prices
AHGP Historical Stock Prices
AHR Historical Stock Prices
AIC Historical Stock Prices


AGE Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.